Perimenopause, menopause, bioidenticals and the evidence — a physician framework for hormone optimization at every life stage.

Perimenopause is the 4-10 year transition before menopause, marked by rising FSH, erratic estrogen, declining progesterone, then full hypoestrogenism. Our approach: map symptoms, confirm with labs, then tailor treatment using modern HRT protocols or evidence-based non-hormonal options.

Bioidentical hormones are molecularly identical to those your body produces. FDA-approved formulations like 17β-estradiol and micronized progesterone have strong safety data, while compounded claims often lack evidence.
Bioidentical hormones are molecularly identical to human hormones—but the term doesn't guarantee safety or superiority. FDA-approved bioidenticals like estradiol patches differ critically from compounded formulations.